Breast Cancer Clinical Trials in Honolulu, Hawaii
6 studies are recruiting for breast cancer in Honolulu, Hawaii right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Kaiser Permanente Hawaii Moanalua Medical Center, Honolulu, Hawaii
- Locations
- 567 in total
- Run by
- Stemline Therapeutics, Inc.
-
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with es…
- Stage
- Phase 3
- Ages
- 18 to 60
- Site
- Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii
- Locations
- 1261 in total
- Run by
- NRG Oncology
-
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
This is a Phase III, randomised, open-label, 3-arm, multicentre, international study assessing the efficacy and safety of Dato-DXd with or without durvalumab compared with investigator's choice chemotherapy in combination with pembrolizumab in participants with PD-L1 positive locally recurrent inop…
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Research Site, Honolulu, Hawaii
- Locations
- 320 in total
- Run by
- AstraZeneca
-
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
This phase 3 clinical trial compares the efficacy and safety of palazestrant with ribociclib to letrozole and ribociclib in women and men who have not received prior systemic anti-cancer treatment for advanced breast cancer.
- Stage
- Phase 3
- Ages
- 18 and older
- Site
- Clinical Trial Site, Honolulu, Hawaii
- Locations
- 181 in total
- Run by
- Olema Pharmaceuticals, Inc.
-
E-Mindfulness Approaches for Living After Breast Cancer
NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and an app-based, self-paced version (MAPs App). Participants wi…
- Stage
- Phase 3
- Ages
- 18 to 50
- Site
- Kaiser Permanente Moanalua Medical Center, Honolulu, Hawaii
- Locations
- 383 in total
- Run by
- NRG Oncology
-
EXoPERT EMERALD Clinical Study
The purpose of this study is to establish a multi-center clinical repository of blood samples to support the development and evaluation of an artificial intelligence-based in vitro diagnostic software. The software analyzes surface-enhanced Raman spectroscopy (SERS) profiles of extracellular vesicl…
- Stage
- Not phased
- Ages
- 45 and older
- Site
- University of Hawaii Cancer Center, Honolulu, Hawaii
- Locations
- 9 in total
- Run by
- EXoPERT
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.